124 related articles for article (PubMed ID: 37988232)
1. Human papillomavirus type 16 E6 promotes cervical cancer proliferation by upregulating transketolase enzymatic activity through the activation of protein kinase B.
Hao S; Meng Q; Sun H; Yang X; Liu B; Zhang Y; Zhou H; Xu Z; Wang Y
Mol Carcinog; 2024 Feb; 63(2):339-355. PubMed ID: 37988232
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus-16 E6 activates the pentose phosphate pathway to promote cervical cancer cell proliferation by inhibiting G6PD lactylation.
Meng Q; Zhang Y; Sun H; Yang X; Hao S; Liu B; Zhou H; Wang Y; Xu ZX
Redox Biol; 2024 May; 71():103108. PubMed ID: 38457903
[TBL] [Abstract][Full Text] [Related]
3. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
4. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
[TBL] [Abstract][Full Text] [Related]
5. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
7. miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6.
Xu J; Wan X; Chen X; Fang Y; Cheng X; Xie X; Lu W
Sci Rep; 2016 Jul; 6():28968. PubMed ID: 27364926
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of Lonicera japonica-derived exosomal miR2911 on human papilloma virus.
Chi Y; Shi L; Lu S; Cui H; Zha W; Shan L; Shen Y
J Ethnopharmacol; 2024 Jan; 318(Pt B):116969. PubMed ID: 37516391
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinase 9 promotes cervical cancer development via AKT2/p53 pathway.
Xu J; Xu S; Fang Y; Chen T; Xie X; Lu W
IUBMB Life; 2019 Mar; 71(3):347-356. PubMed ID: 30536701
[TBL] [Abstract][Full Text] [Related]
11. Repression of Memo1, a Novel Target of Human Papillomavirus Type 16 E7, Increases Cell Proliferation in Cervical Cancer Cells.
Trejo-Cerro O; Massimi P; Broniarczyk J; Myers M; Banks L
J Virol; 2022 Oct; 96(20):e0122922. PubMed ID: 36197110
[TBL] [Abstract][Full Text] [Related]
12. Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker P16 (INK4a) are useful prognostic markers in uterine cervical carcinomas in Qassim Region--Saudi Arabia.
Omran OM; AlSheeha M
Pathol Oncol Res; 2015 Jan; 21(1):157-66. PubMed ID: 24925218
[TBL] [Abstract][Full Text] [Related]
13. Degradation of p53 by HPV16-E6 variants isolated from cervical cancer specimens of Moroccan women.
Hadami K; Saby C; Dakka N; Collin G; Attaleb M; Khyatti M; Filali-Maltouf A; Morjani H; El Mzibri M
Gene; 2021 Jul; 791():145709. PubMed ID: 33984442
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
[TBL] [Abstract][Full Text] [Related]
15. HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m
Hu C; Liu T; Han C; Xuan Y; Jiang D; Sun Y; Zhang X; Zhang W; Xu Y; Liu Y; Pan J; Wang J; Fan J; Che Y; Huang Y; Zhang J; Ding J; Yang S; Yang K
Int J Biol Sci; 2022; 18(2):507-521. PubMed ID: 35002506
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of miR-20a by HPV16 E6 exerts growth-promoting effects by targeting PDCD6 in cervical carcinoma cells.
Liu X
Biomed Pharmacother; 2018 Jun; 102():996-1002. PubMed ID: 29710555
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
Hirao N; Iwata T; Tanaka K; Nishio H; Nakamura M; Morisada T; Morii K; Maruyama N; Katoh Y; Yaguchi T; Ohta S; Kukimoto I; Aoki D; Kawakami Y
Gynecol Oncol; 2019 Nov; 155(2):340-348. PubMed ID: 31477279
[TBL] [Abstract][Full Text] [Related]
18. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3β inactivation promotes cervical cancer progression, invasion, and drug resistance.
Nath N; Rana A; Nagini S; Mishra R
Biotechnol Appl Biochem; 2022 Oct; 69(5):1929-1941. PubMed ID: 34554598
[TBL] [Abstract][Full Text] [Related]
20. E6 Protein Expressed by High-Risk HPV Activates Super-Enhancers of the
Chen X; Loo JX; Shi X; Xiong W; Guo Y; Ke H; Yang M; Jiang Y; Xia S; Zhao M; Zhong S; He C; Fu L; Li F
Cancer Res; 2018 Mar; 78(6):1418-1430. PubMed ID: 29339538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
